Sutro Biopharma Inc
NASDAQ:STRO
Income Statement
Earnings Waterfall
Sutro Biopharma Inc
Revenue
|
153.7m
USD
|
Operating Expenses
|
-243m
USD
|
Operating Income
|
-89.3m
USD
|
Other Expenses
|
-17.5m
USD
|
Net Income
|
-106.8m
USD
|
Income Statement
Sutro Biopharma Inc
Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||
Revenue |
33
N/A
|
23
-29%
|
38
+64%
|
41
+7%
|
46
+12%
|
51
+10%
|
43
-15%
|
41
-3%
|
40
-3%
|
46
+14%
|
43
-7%
|
50
+18%
|
69
+37%
|
60
-14%
|
62
+4%
|
53
-14%
|
53
+0%
|
70
+31%
|
68
-3%
|
75
+10%
|
57
-24%
|
49
-14%
|
154
+216%
|
|
Operating Income | ||||||||||||||||||||||||
Operating Expenses |
(73)
|
(72)
|
(76)
|
(81)
|
(87)
|
(94)
|
(98)
|
(102)
|
(103)
|
(107)
|
(114)
|
(121)
|
(133)
|
(148)
|
(160)
|
(172)
|
(181)
|
(185)
|
(197)
|
(207)
|
(216)
|
(230)
|
(243)
|
|
Selling, General & Administrative |
(17)
|
(18)
|
(21)
|
(25)
|
(29)
|
(31)
|
(33)
|
(34)
|
(34)
|
(35)
|
(37)
|
(39)
|
(43)
|
(51)
|
(56)
|
(60)
|
(63)
|
(61)
|
(60)
|
(60)
|
(60)
|
(61)
|
(63)
|
|
Research & Development |
(56)
|
(55)
|
(54)
|
(56)
|
(59)
|
(63)
|
(66)
|
(68)
|
(69)
|
(72)
|
(77)
|
(82)
|
(90)
|
(97)
|
(104)
|
(112)
|
(119)
|
(124)
|
(137)
|
(147)
|
(156)
|
(170)
|
(180)
|
|
Operating Income |
(40)
N/A
|
(49)
-23%
|
(37)
+24%
|
(40)
-7%
|
(41)
-4%
|
(44)
-6%
|
(55)
-26%
|
(60)
-9%
|
(63)
-5%
|
(61)
+3%
|
(71)
-16%
|
(71)
+0%
|
(64)
+9%
|
(88)
-37%
|
(99)
-12%
|
(119)
-20%
|
(128)
-8%
|
(115)
+10%
|
(129)
-12%
|
(132)
-2%
|
(159)
-20%
|
(182)
-14%
|
(89)
+51%
|
|
Pre-Tax Income | ||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(1)
|
(0)
|
0
|
1
|
0
|
(0)
|
(1)
|
46
|
74
|
39
|
28
|
(15)
|
(39)
|
(7)
|
4
|
(3)
|
(5)
|
12
|
5
|
17
|
18
|
13
|
|
Total Other Income |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(6)
|
(13)
|
|
Pre-Tax Income |
(40)
N/A
|
(49)
-22%
|
(35)
+28%
|
(38)
-6%
|
(40)
-6%
|
(42)
-7%
|
(56)
-31%
|
(61)
-10%
|
(17)
+71%
|
13
N/A
|
(32)
N/A
|
(43)
-33%
|
(79)
-84%
|
(127)
-61%
|
(106)
+17%
|
(114)
-8%
|
(132)
-15%
|
(120)
+9%
|
(117)
+3%
|
(127)
-9%
|
(142)
-12%
|
(170)
-20%
|
(89)
+48%
|
|
Net Income | ||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(3)
|
(3)
|
(1)
|
(2)
|
(18)
|
|
Income from Continuing Operations |
(40)
|
(49)
|
(35)
|
(38)
|
(40)
|
(42)
|
(56)
|
(61)
|
(17)
|
13
|
(32)
|
(43)
|
(79)
|
(127)
|
(106)
|
(114)
|
(134)
|
(123)
|
(119)
|
(130)
|
(143)
|
(172)
|
(107)
|
|
Net Income (Common) |
(40)
N/A
|
(49)
-22%
|
(35)
+28%
|
(38)
-6%
|
(40)
-6%
|
(42)
-7%
|
(56)
-31%
|
(61)
-10%
|
(17)
+71%
|
13
N/A
|
(32)
N/A
|
(43)
-33%
|
(79)
-84%
|
(127)
-61%
|
(106)
+17%
|
(114)
-8%
|
(134)
-17%
|
(123)
+9%
|
(119)
+3%
|
(130)
-9%
|
(143)
-10%
|
(172)
-21%
|
(107)
+38%
|
|
EPS (Diluted) |
-1.81
N/A
|
-2.15
-19%
|
-1.55
+28%
|
-1.66
-7%
|
-1.74
-5%
|
-1.85
-6%
|
-2.43
-31%
|
-2.64
-9%
|
-0.54
+80%
|
0.33
N/A
|
-0.99
N/A
|
-0.93
+6%
|
-1.71
-84%
|
-2.75
-61%
|
-2.29
+17%
|
-2.46
-7%
|
-2.85
-16%
|
-2.34
+18%
|
-2.35
0%
|
-2.21
+6%
|
-2.36
-7%
|
-2.84
-20%
|
-1.78
+37%
|